Skip to main content

Paediatric Services

 Berotralstat for preventing recurrent attacks of hereditary angioedema for people aged 12 years and older, Policy Position Statement (PP236). June 2022 (PDF, 277Kb)
 Cannabidiol with clobazam for treating seizures associated with Dravet syndrome or Lennox–Gastaut syndrome in people aged 2 years and older (PP203), February 2021 (PDF, 545Kb)
 Circumcision for Children, Commissioning Policy, (CP34). March 2019 (PDF, 344Kb)
 CP186 Cleft Lip and or Palate including Non-Cleft Velopharyngeal Dysfunction All Ages (PDF, 680Kb)
 Dexrazoxane for Preventing Cardiotoxicity in Children (Aged Under 16 Years Old) Receiving High-Dose Anthracyclines or Related Drugs for the Treatment of Cancer, Policy Position Statement (PP253), February 2023 (PDF, 265Kb)
 Nusinersen for treating spinal muscular atrophy, Policy Position Statement, (PP191). January 2022 (PDF, 399Kb)
 CP163 Paediatric Endocrinology (PDF, 283Kb)
 Paediatric Epilepsy, Commissioning Policy (CP174), September 2022 (PDF, 487Kb)
 Paediatric Nephrology Service Specification CP169 (March 2021) (PDF, 443Kb)
 Risdiplam for Spinal Muscular Atrophy for people aged under 16 years, Policy Position Statement (PP240). May 2022 (PDF, 361Kb)
 South Wales Neonatal Transport Operational Delivery Network, (CP244) October 2022 (PDF, 303Kb)
 Specialised Paediatric Rheumatology Service Specification (CP172). November 2021 (PDF, 475Kb)
 Tofacitinib for treating juvenile idiopathic arthritis in people aged 2 to 16 years, Policy Position Statement (PP229). May 2022 (PDF, 311Kb)